TrialThe Lancet. Infectious diseases2013

Efficacy and safety of raltegravir for treatment of HIV for 5 years in the BENCHMRK studies: final results of two randomised, placebo-controlled trials.

Joseph J Eron et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.